3rd Quarter - Report

CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION

Firm
Client
Income
—
Expenses
$70,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA (EXPERRT, PDUFA) follow up, Board on the Hill, Appropriations and Sequestration (NIH & FDA), Teen Advocacy Day follow up, Congressional CF Caucus, Congressional Briefings, Make Every Breath Count grassroots campaign, 340B, Meeting with White House Science and Technology office, communications to grassroots advocates, Essential Health Benefits & Exchanges under PPACA, coverage for Kalydeco, Medicaid drug coverage

LobbyistCovered position, as disclosed
ERIC CHAMBERLAIN —
MARY B DWIGHT Legislative Correspondent; Legislative Assistant
JACQUELINE ERDO —
STEPHANIE KRENRICH Sr. Leg. Asst; Leg. Asst.; Leg Aide; Leg. Corr.
JASON RANVILLE —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.